{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:36:30Z","timestamp":1780536990898,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R21DA054261-01"],"award-info":[{"award-number":["1R21DA054261-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K12 HS026370"],"award-info":[{"award-number":["K12 HS026370"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s11606-023-08586-6","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T14:02:20Z","timestamp":1705413740000},"page":"2179-2186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Patients\u2019 and Clinicians\u2019 Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8449-7701","authenticated-orcid":false,"given":"Tamar","family":"Wyte-Lake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena A.","family":"Levander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie Kirkman","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffani R.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"issue":"12","key":"8586_CR1","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.mayocp.2020.10.011","volume":"95","author":"TS Oesterle","year":"2020","unstructured":"Oesterle TS, Kolla B, Risma CJ, et al. Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook. Mayo Clinic Proceedings. 2020;95(12):2709-2718. https:\/\/doi.org\/10.1016\/j.mayocp.2020.10.011","journal-title":"Mayo Clin Proc."},{"issue":"2","key":"8586_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1377\/hlthaff.2022.00803","volume":"42","author":"L Uscher-Pines","year":"2023","unstructured":"Uscher-Pines L, Riedel LE, Mehrotra A, Rose S, Busch AB, Huskamp HA. Many Clinicians Implement Digital Equity Strategies To Treat Opioid Use Disorder. Health Affairs. 2023;42(2):182-186. https:\/\/doi.org\/10.1377\/hlthaff.2022.00803","journal-title":"Health Affairs."},{"issue":"9","key":"8586_CR3","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/10826084.2023.2212378","volume":"58","author":"SR Bailey","year":"2023","unstructured":"Bailey SR, Wyte-Lake T, Lucas JA, et al. Use of Telehealth for Opioid Use Disorder Treatment in Safety Net Primary Care Settings: A Mixed-Methods Study. Subst Use Misuse. 2023;58(9):1143-1151. https:\/\/doi.org\/10.1080\/10826084.2023.2212378","journal-title":"Subst Use Misuse."},{"key":"8586_CR4","doi-asserted-by":"publisher","first-page":"103703","DOI":"10.1016\/j.drugpo.2022.103703","volume":"105","author":"L Textor","year":"2022","unstructured":"Textor L, Ventricelli D, Aronowitz SV. \u2018Red Flags\u2019 and \u2018Red Tape\u2019: Telehealth and pharmacy-level barriers to buprenorphine in the United States. Int J Drug Policy. 2022;105:103703. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103703","journal-title":"Int J Drug Policy."},{"issue":"3","key":"8586_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jrh.12570","volume":"37","author":"PM Hughes","year":"2021","unstructured":"Hughes PM, Verrastro G, Fusco CW, Wilson CG, Ostrach B. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic. J Rural Health. 2021;37(3):467-472. https:\/\/doi.org\/10.1111\/jrh.12570","journal-title":"J Rural Health."},{"issue":"3","key":"8586_CR6","doi-asserted-by":"publisher","first-page":"e220093","DOI":"10.1001\/jamahealthforum.2022.0093","volume":"3","author":"AS Tilhou","year":"2022","unstructured":"Tilhou AS, Dague L, Saloner B, Beemon D, Burns M. Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic. JAMA Health Forum. 2022;3(3):e220093-e220093. https:\/\/doi.org\/10.1001\/jamahealthforum.2022.0093","journal-title":"JAMA Health Forum."},{"issue":"1","key":"8586_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13011-021-00395-6","volume":"16","author":"K Alexander","year":"2021","unstructured":"Alexander K, Pogorzelska-Maziarz M, Gerolamo A, Hassen N, Kelly EL, Rising KL. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review. Subst Abuse Treat Prev Policy. 2021;16(1):60. https:\/\/doi.org\/10.1186\/s13011-021-00395-6","journal-title":"Subst Abuse Treat Prev Policy."},{"issue":"23","key":"8586_CR8","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1001\/jama.2020.22154","volume":"324","author":"JD Cance","year":"2020","unstructured":"Cance JD, Doyle E. Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic. JAMA. 2020;324(23):2442-2444. https:\/\/doi.org\/10.1001\/jama.2020.22154","journal-title":"JAMA."},{"issue":"6","key":"8586_CR9","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1097\/adm.0000000000000756","volume":"14","author":"JD Thornton","year":"2020","unstructured":"Thornton JD, Varisco TJ, Bapat SS, Downs CG, Shen C. Impact of COVID-19 Related Policy Changes on Buprenorphine Dispensing in Texas. J Addict Med. 2020;14(6):e372-e374. https:\/\/doi.org\/10.1097\/adm.0000000000000756","journal-title":"J Addict Med."},{"key":"8586_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.2284","author":"CM Jones","year":"2022","unstructured":"Jones CM, Shoff C, Hodges K, et al. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic. JAMA Psychiatry. 2022;https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.2284","journal-title":"JAMA Psychiatry."},{"issue":"1","key":"8586_CR11","doi-asserted-by":"publisher","first-page":"e2252381","DOI":"10.1001\/jamanetworkopen.2022.52381","volume":"6","author":"R Hailu","year":"2023","unstructured":"Hailu R, Mehrotra A, Huskamp HA, Busch AB, Barnett ML. Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic. JAMA Network Open. 2023;6(1):e2252381-e2252381. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.52381","journal-title":"JAMA Network Open."},{"issue":"1","key":"8586_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12954-021-00572-7","volume":"18","author":"SV Aronowitz","year":"2021","unstructured":"Aronowitz SV, Engel-Rebitzer E, Dolan A, et al. Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives. Harm Reduction J. 2021;18(1):119. https:\/\/doi.org\/10.1186\/s12954-021-00572-7","journal-title":"Harm Reduc J."},{"issue":"1","key":"8586_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1370\/afm.2184","volume":"16","author":"RE Cantone","year":"2018","unstructured":"Cantone RE, Fleishman J, Garvey B, Gideonse N. Interdisciplinary Management of Opioid Use Disorder in Primary Care. Annals Family Med. 2018;16(1):83-83. https:\/\/doi.org\/10.1370\/afm.2184","journal-title":"Annals Family Med."},{"issue":"5","key":"8586_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1176\/appi.ps.202100088","volume":"73","author":"TL Mark","year":"2022","unstructured":"Mark TL, Treiman K, Padwa H, Henretty K, Tzeng J, Gilbert M. Addiction Treatment and Telehealth: Review of Efficacy and Provider Insights During the COVID-19 Pandemic. Psychiatr Serv. 2022;73(5):484-491. https:\/\/doi.org\/10.1176\/appi.ps.202100088","journal-title":"Psychiatr Serv."},{"issue":"6","key":"8586_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/adm.0000000000001006","volume":"16","author":"JL Sousa","year":"2022","unstructured":"Sousa JL, Raja P, Huskamp HA, et al. Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences. J Addiction Med. 2022;16(6):702-708. https:\/\/doi.org\/10.1097\/adm.0000000000001006","journal-title":"J Addic Med."},{"key":"8586_CR16","doi-asserted-by":"publisher","first-page":"108124","DOI":"10.1016\/j.jsat.2020.108124","volume":"118","author":"L Uscher-Pines","year":"2020","unstructured":"Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett M, Huskamp HA. Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine. J Subst Abuse Treat. 2020;118:108124. https:\/\/doi.org\/10.1016\/j.jsat.2020.108124","journal-title":"J Subst Abuse Treat."},{"issue":"1","key":"8586_CR17","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/08897077.2022.2060447","volume":"43","author":"R Lockard","year":"2022","unstructured":"Lockard R, Priest KC, Gregg J, Buchheit BM. A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19. Substance Abuse. 2022;43(1):1155-1162. https:\/\/doi.org\/10.1080\/08897077.2022.2060447","journal-title":"Substance Abuse."},{"key":"8586_CR18","doi-asserted-by":"publisher","unstructured":"Bailey SR, Wyte-Lake T, Lucas JA, et al. Use of Telehealth for Opioid Use Disorder Treatment in Safety Net Primary Care Settings: A Mixed-Methods Study. Substance Use Misuse. 2023:1-9. https:\/\/doi.org\/10.1080\/10826084.2023.2212378","DOI":"10.1080\/10826084.2023.2212378"},{"key":"8586_CR19","doi-asserted-by":"publisher","unstructured":"Lott AM, Danner AN, Malte CA, et al. Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation. J Addict Med. 2023;https:\/\/doi.org\/10.1097\/adm.0000000000001156","DOI":"10.1097\/adm.0000000000001156"},{"key":"8586_CR20","doi-asserted-by":"crossref","unstructured":"Huskamp HA, Riedel L, Campa I, et al. Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians. J Gen Int Med. 2023:1-8.","DOI":"10.1007\/s11606-023-08165-9"},{"issue":"3","key":"8586_CR21","doi-asserted-by":"publisher","first-page":"e36260","DOI":"10.7759\/cureus.36260","volume":"15","author":"B Al Hemyari","year":"2023","unstructured":"Al Hemyari B, Coffey N, Inman ZW, Singh A. Healthcare Providers\u2019 Experience Using Telehealth During the Onset of the COVID-19 Pandemic in a Predominantly Rural Patient Base: An Online Survey. Cureus. 2023;15(3):e36260. https:\/\/doi.org\/10.7759\/cureus.36260","journal-title":"Cureus."},{"key":"8586_CR22","unstructured":"Duff N, Freiling E, Burstin H, Clark K, Salman A. NAM Action Collaborative on Countering the U.S. Opioid Epidemic Telehealth and Virtual Care Meeting Series: Introduction to Improving Telehealth and Virtual Care for Pain Management and Opioid\/Substance Use Disorder. 2022"},{"issue":"10","key":"8586_CR23","doi-asserted-by":"publisher","first-page":"e2236298","DOI":"10.1001\/jamanetworkopen.2022.36298","volume":"5","author":"MC Frost","year":"2022","unstructured":"Frost MC, Zhang L, Kim HM, Lin L. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Network Open. 2022;5(10):e2236298-e2236298. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.36298","journal-title":"JAMA Network Open."},{"key":"8586_CR24","doi-asserted-by":"publisher","unstructured":"Patel SY, Ortiz EG, Barsky BA, Huskamp HA, Busch AB, Mehrotra A. Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries. J Gen Intern Med. 2022:1-4. https:\/\/doi.org\/10.1007\/s11606-022-07633-y","DOI":"10.1007\/s11606-022-07633-y"},{"issue":"1","key":"8586_CR25","doi-asserted-by":"publisher","first-page":"e2142531","DOI":"10.1001\/jamanetworkopen.2021.42531","volume":"5","author":"BA Barsky","year":"2022","unstructured":"Barsky BA, Busch AB, Patel SY, Mehrotra A, Huskamp HA. Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage. JAMA Network Open. 2022;5(1):e2142531-e2142531. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.42531","journal-title":"JAMA Network Open."},{"issue":"1","key":"8586_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1186\/s12913-023-09994-4","volume":"23","author":"D Klee","year":"2023","unstructured":"Klee D, Pyne D, Kroll J, James W, Hirko KA. Rural patient and provider perceptions of telehealth implemented during the COVID-19 pandemic. BMC Health Serv Res.\u00a0 2023;23(1):981. https:\/\/doi.org\/10.1186\/s12913-023-09994-4","journal-title":"BMC Health Serv Res."},{"issue":"2","key":"8586_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1037\/fsh0000619","volume":"39","author":"H Angier","year":"2021","unstructured":"Angier H, Fleishman J, Gordon L, Cohen DJ, Cantone RE, Bailey SR. Tier-based treatment for opioid use disorder in the primary care setting. Fam Syst Health. 39(2):345-350. https:\/\/doi.org\/10.1037\/fsh0000619","journal-title":"Fam Syst Health"},{"issue":"2","key":"8586_CR28","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1098214005283748","volume":"27","author":"DR Thomas","year":"2006","unstructured":"Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Ame J Eval. 2006;27(2):237-246.","journal-title":"Ame J Eval."},{"issue":"6","key":"8586_CR29","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Quality Health Care. 2007;19(6):349-357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042","journal-title":"Int J Quality Health Care."},{"issue":"6","key":"8586_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/tmj.2021.0308","volume":"28","author":"AG Guillen","year":"2022","unstructured":"Guillen AG, Reddy M, Saadat S, Chakravarthy B. Utilization of Telehealth Solutions for Patients with Opioid Use Disorder Using Buprenorphine: A Scoping Review. Telemed J E Health. 2022;28(6):761-767. https:\/\/doi.org\/10.1089\/tmj.2021.0308","journal-title":"Telemed J E Health."},{"issue":"14","key":"8586_CR31","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/jama.2023.1307","volume":"329","author":"L Uscher-Pines","year":"2023","unstructured":"Uscher-Pines L, McCullough CM, Sousa JL, et al. Changes in In-Person, Audio-Only, and Video Visits in California\u2019s Federally Qualified Health Centers, 2019-2022. JAMA. 2023;329(14):1219-1221. https:\/\/doi.org\/10.1001\/jama.2023.1307","journal-title":"JAMA."},{"key":"8586_CR32","doi-asserted-by":"publisher","unstructured":"Lin LA, Zhang L, Kim HM, Frost MC. Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder. Am J Psychiatry. 2022:appiajp21111141. https:\/\/doi.org\/10.1176\/appi.ajp.21111141","DOI":"10.1176\/appi.ajp.21111141"},{"issue":"10","key":"8586_CR33","doi-asserted-by":"publisher","first-page":"e2236298","DOI":"10.1001\/jamanetworkopen.2022.36298","volume":"5","author":"MC Frost","year":"2022","unstructured":"Frost MC, Zhang L, Kim HM, Lin LA. Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. JAMA Network Open. 2022;5(10):e2236298-e2236298.","journal-title":"JAMA Network Open."},{"issue":"3","key":"8586_CR34","doi-asserted-by":"publisher","first-page":"ooab056","DOI":"10.1093\/jamiaopen\/ooab056","volume":"4","author":"JW Sachs","year":"2021","unstructured":"Sachs JW, Graven P, Gold JA, Kassakian SZ. Disparities in telephone and video telehealth engagement during the COVID-19 pandemic. JAMIA Open.\u00a02021;4(3):ooab056. https:\/\/doi.org\/10.1093\/jamiaopen\/ooab056","journal-title":"JAMIA Open."},{"key":"8586_CR35","unstructured":"National Trends in Telehealth Use in 2021:Disparities in Utilization and Audio vs. Video Services.(Research Report No.HP-2022-04) (Office of the Assistant Secretary for Planning and Evaluation, U. S. Department of Health and Human Services) (February 2022)."},{"issue":"5","key":"8586_CR36","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s11606-021-07172-y","volume":"37","author":"J Chen","year":"2022","unstructured":"Chen J, Li KY, Andino J, et al. Predictors of Audio-Only Versus Video Telehealth Visits During the COVID-19 Pandemic. J Gen Int Med. 2022;37(5):1138-1144. https:\/\/doi.org\/10.1007\/s11606-021-07172-y","journal-title":"J Gen Int Med."},{"key":"8586_CR37","unstructured":"National Institute on Drug Abuse. Harm Reduction. Accessed December 4, 2023, https:\/\/nida.nih.gov\/research-topics\/harm-reduction"},{"key":"8586_CR38","doi-asserted-by":"publisher","first-page":"108219","DOI":"10.1016\/j.jsat.2020.108219","volume":"122","author":"G Joseph","year":"2021","unstructured":"Joseph G, Torres-Lockhart K, Stein MR, Mund PA, Nahvi S. Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19. Journal of substance abuse treatment. 2021;122:108219.","journal-title":"J Subs Abuse Treat."},{"key":"8586_CR39","doi-asserted-by":"publisher","first-page":"108155","DOI":"10.1016\/j.jsat.2020.108155","volume":"120","author":"JD Pytell","year":"2021","unstructured":"Pytell JD, Rastegar DA. Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic. J Substance Abuse Treat. 2021;120:108155. https:\/\/doi.org\/10.1016\/j.jsat.2020.108155","journal-title":"Journal of Substance Abuse Treatment."},{"issue":"11","key":"8586_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adaw.33712","volume":"35","author":"A Knopf","year":"2023","unstructured":"Knopf A. DEA proposes limits on telehealth for buprenorphine. Alcohol Drug Abuse Weekly. 2023;35(11):1-3. https:\/\/doi.org\/10.1002\/adaw.33712","journal-title":"Alcoholism & Drug Abuse Weekly."},{"key":"8586_CR41","unstructured":"Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. In: Drug Enforcement Administration, editor. 88 FR 300372023. 30037-30043."},{"issue":"10","key":"8586_CR42","doi-asserted-by":"publisher","first-page":"e2336914","DOI":"10.1001\/jamanetworkopen.2023.36914","volume":"6","author":"LR Hammerslag","year":"2023","unstructured":"Hammerslag LR, Mack A, Chandler RK, et al. Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees. JAMA network open. 2023;6(10):e2336914-e2336914.","journal-title":"JAMA Network Open."},{"key":"8586_CR43","unstructured":"Pham H, Lin C, Zhu Y, et al. Telemedicine-delivered treatment for substance use disorder: A scoping review. J Telemed Telecare. 2023:1357633X231190945."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08586-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-023-08586-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08586-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:10:04Z","timestamp":1764267004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-023-08586-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["8586"],"URL":"https:\/\/doi.org\/10.1007\/s11606-023-08586-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"28 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}